alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

                                                                      EXHIBIT 12

PG&E GAS TRANSMISSION, NORTHWEST CORPORATION
SEC FILING - FORM 10-K - Year End 2001
EXHIBIT 12 - RATIO OF EARNINGS TO FIXED CHARGES

<TABLE>
<CAPTION>
Ratio of earnings to Fixed Charges            2001            2000            1999           1998            1997
----------------------------------         ------------    ------------    ------------   ------------    ------------
<S>                                        <C>             <C>             <C>            <C>             <C>
Earnings

     Income from Continuing Operations          $ 75.4          $ 58.4          $ 61.5         $ 60.3          $ 42.1
Adjustments:
     Income taxes                                 34.5            37.4            37.6           35.7            24.8
     Fixed charges (as below)                     38.0            40.9            42.8           44.1            46.7
                                           ------------    ------------    ------------   ------------    ------------
              Total adjusted earnings           $147.9          $136.7          $141.9         $140.1          $113.6
                                           ============    ============    ============   ============    ============



Fixed charges:
     Net interest expense                       $ 37.0          $ 40.4          $ 41.7         $ 43.0          $ 46.0
Adjustments:
     Interest component of rents                   0.3             0.1             0.0            0.1             0.4
     AFUDC debt                                    0.7             0.4             1.1            1.0             0.3
                                           ------------    ------------    ------------   ------------    ------------
              Total fixed charges               $ 38.0          $ 40.9          $ 42.8         $ 44.1          $ 46.7
                                           ============    ============    ============   ============    ============


                                           ------------    ------------    ------------   ------------    ------------
Ratio of earnings to fixed charges                 3.9             3.3             3.3            3.2             2.4
                                           ============    ============    ============   ============    ============
</TABLE>
[Federal Register Volume 89, Number 185 (Tuesday, September 24, 2024)]
[Notices]
[Page 77875]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21740]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel; Review of Support for Research 
Excellence (SuRE) Program and Support for Research Excellence--First 
Independent Research (SuRE-First) Award (R16).
    Date: October 31-November 1, 2024.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute of 
General Medical Sciences, Natcher Building, 45 Center Drive, 
Bethesda, Maryland 20892 (Virtual Meeting).
    Contact Person: John J. Laffan, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Institute of General 
Medical Sciences, National Institutes of Health, Natcher Building, 
45 Center Drive, Room 3AN18J, Bethesda, Maryland 20892, 301-594-
2773, <a href="/cdn-cgi/l/email-protection#325e535454535c585d725f535b5e1c5c5b5a1c555d44"><span class="__cf_email__" data-cfemail="95f9f4f3f3f4fbfffad5f8f4fcf9bbfbfcfdbbf2fae3">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program No. 93.859, 
Biomedical Research and Research Training, National Institutes of 
Health, HHS)

    Dated: September 18, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-21740 Filed 9-23-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
# C_2022160EN.01001201.xml

| 13.4.2022 | EN | Official Journal of the European Union | C 160/12 |
| --- | --- | --- | --- |

13.4.2022

EN

Official Journal of the European Union

C 160/12

---

Non-opposition to a notified concentration

(Case M.10675 – CDPQ / TRANSURBAN / AUSTRALIANSUPER / CPP INVESTMENTS / ADIA / WCX)

(Text with EEA relevance)

(2022/C 160/05)

On 1 April 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10675. EUR-Lex is the online point of access to European Union law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10675. EUR-Lex is the online point of access to European Union law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
# C_2022115EN.01001201.xml

| 11.3.2022 | EN | Official Journal of the European Union | C 115/12 |
| --- | --- | --- | --- |

11.3.2022

EN

Official Journal of the European Union

C 115/12

---

Notice for the attention of the persons and entities subject to the restrictive measures provided for in Council Decision 2014/145/CFSP, as amended by Council Decision (CFSP) 2022/411, and in Council Regulation (EU) No 269/2014 as implemented by Council Implementing Regulation (EU) 2022/408 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of Ukraine

(2022/C 115/06)

The following information is brought to the attention of the persons and entities that appear in the Annex to Council Decision 2014/145/CFSP (1), as amended by Council Decision (CFSP) 2022/411 (2), and in Annex I to Council Regulation (EU) No 269/2014 (3), as implemented by Council Implementing Regulation (EU) 2022/408 (4) concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of Ukraine.

The Council of the European Union, after having reviewed the list of persons and entities designated in the above-mentioned Annexes, has determined that the restrictive measures provided for in Decision 2014/145/CFSP and in Regulation (EU) No 269/2014 should continue to apply to those persons and entities.

The attention of the persons and entities concerned is drawn to the possibility of making an application to the competent authorities of the relevant Member State(s) as indicated in the websites in Annex II to Regulation (EU) No 269/2014, in order to obtain an authorisation to use frozen funds for basic needs or specific payments (cf. Article 4 of the Regulation).

The persons and entities concerned may submit a request to the Council, together with supporting documentation, that the decision to include them on the abovementioned list should be reconsidered, to the following address before 1 June 2022:

| Council of the European Union |
| --- |
| General Secretariat |
| RELEX.1 |
| Rue de la Loi/Wetstraat 175 |
| 1048 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

Council of the European Union

General Secretariat

RELEX.1

Rue de la Loi/Wetstraat 175

1048 Bruxelles/Brussel

BELGIQUE/BELGIË

Email: sanctions@consilium.europa.eu

The attention of the persons and entities concerned is also drawn to the possibility of challenging the Council’s decision before the General Court of the European Union, in accordance with the conditions laid down in Article 275, second paragraph, and Article 263, fourth and sixth paragraphs, of the Treaty on the Functioning of the European Union.

---

(1)  OJ L 78, 17.3.2014, p. 16.

(2)  OJ L 84, 11.3.2022, p. 28.

(3)  OJ L 78, 17.3.2014, p. 6.

(4)  OJ L 84, 11.3.2022, p. 2.

---
•I Chemours ('[-''"-. /\'C . (\ ;l..r. i/ r:tJ 

OPPT Ci.lie 

20 I 6 APfi - 4 M1 II: O I 

The Chemours Company 

Fluoroproducts 

67 Canal Road, P. 0. Box 9001 

Chambers Works R Pedersen Building 

Deepwater, NJ 08023 

CBIC Control Number 

368770 

March 23, 2016 

Certified Mail - Return Receipt Requested 

70150640000596575640 RECEIVED 

IVl/-\I 0 3 2016 

EPA DOCKET CENTER 

Director, Chemical Control Division 

US Environmental Protection Agency 

Office of Pollution Prevention and Toxics 

EPA East 

Room 4146 

1201 Constitution Avenue, NW 

Washington, DC 20004 

RE: EPA-HQ-OPPT-2003- 0012 

Chemours Chambers Works NJPDES Permit No. NJOOOSlOO 

PFOA Data Submittal- Outfall DSN662 Weekly Grab Samples 

February 2016 Sample Data 

Dear Chemical Control Division: 

Attached please find summaries of PFOA analytical results for the Chem ours 

Chambers Works weekly grab samples talcen at internal outfall DSN662A in 

February 2016. 

In accordance with the current site NJPDES permit (NJ0005100, effective September 

2011), these results are provided to NJDEP on a monthly basis via electronic 

discharge monitoring repmis. The enclosures include two paper and two electronic 

copies of the analytical results from this monitoring period. 

NJDEP asked The Chemours Company FC, LLC to analyze for and report monthly 

Spot 662 PFNA concentrations for 12 months. The eighth of the requested 12 

samples is repmied in the attached table. 

Sincerely, 

l 

Arnut a J eyaraj asingam 

Area Manager - Secure Environmental Treatment 

Chemours Chambers Works 

AJ/clc 
Copy to: 

Document Control Office 

US Environmental Protection Agency 

Office of Pollution Prevention and Toxics 

EPA East 

Room6428 

1200 Pennsylvania Avenue, NW 

Washington, DC 20460 

Ms. Heather Genievich (cover letter only) 

NJDEP Division of Water Quality 

Bureau of Surface Water Permitting 

Mail Code 401-02B 

401 E. State Street 

P.O. Box420 

Trenton, NJ 08625-0420 
Analyte 

Pt-OA 

PFNA 

Sample ID 

Date 

Top (ft) 

Total (T)/ Bottom (ft) 

units Diss. (D) Duplicate# 

ug/L T 

ug/L T 

Summary of Analytical Results 

662 - February 2016 

662-GRAB 662-GRABI 662-GRAB 662-GRAB 662-GRAB 662-GRAB 

2/1/16 2/8/16 2/18/16 2/22/16 2/23/16 2/29/16 

0 0 0 0 0 0 

0 0 0 a 0 0 

1 1 1 1 1 1 

3.50 5.70 2.84 4.35 .4.01 5.84 

NA NA NA 0.682 NA NA 

PFNA = Perfluorononanoic Acid 

PFOA = Perfluorooctanoic Acid 

ug/L - micrograms per Liter 

ug/L =micrograms per liter or parts per billion (ppo) 

LOQ = limit of quantification - 0.1 DO ug/L 

NA - not analyzed 

Samples were analyzed by Critical Path Services LLC. Reported results 

represent a single analysis, except for the samples collected on 2118 and 2/22/16. 

Acceptable precision vyas obtained and the reported results for 

the samples collected on 2118 and 2/22/16 represent the average of lab 

duplicate results. 

The NJDEP lab certification number for Critical Path Services LLC is PA072. 

I 

I 

' 

< and ND = Non detect at stated reporting limit Page 1 of 1 

Copy of cwk 662 grab results_feb16 rev.xls:Sheet1 

3/24/2016 1 :50 PM
[Federal Register Volume 89, Number 183 (Friday, September 20, 2024)]
[Notices]
[Page 77169]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21562]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF THE INTERIOR

Bureau of Indian Affairs

[245A2100DD/AAKC001030/A0A501010.999900]


Indian Gaming; Extension of Tribal-State Class III Gaming Compact 
in California

AGENCY: Bureau of Indian Affairs, Interior.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces the extension of the Class III gaming 
compact between the Alturas Indian Rancheria and the State of 
California.

DATES: The extension takes effect on September 20, 2024.

FOR FURTHER INFORMATION CONTACT: Ms. Paula L. Hart, Director, Office of 
Indian Gaming, Office of the Assistant Secretary--Indian Affairs, 
Washington, DC 20240, <a href="/cdn-cgi/l/email-protection#fbb2959f929a95bc9a9692959cbb99929ad59c948d"><span class="__cf_email__" data-cfemail="662f08020f070821070b0f080126040f0748010910">[email protected]</span></a>; (202) 219-4066.

SUPPLEMENTARY INFORMATION: An extension to an existing Tribal-State 
Class III gaming compact does not require approval by the Secretary if 
the extension does not modify any other terms of the compact. 25 CFR 
293.5. The Alturas Indian Rancheria and the State of California have 
reached an agreement to extend the expiration date of their existing 
Tribal-State Class III gaming compact to December 31, 2024. This 
publication provides notice of the new expiration date of the compact.

Bryan Newland,
Assistant Secretary--Indian Affairs.
[FR Doc. 2024-21562 Filed 9-19-24; 8:45 am]
BILLING CODE 4337-15-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
FILED

U.S. COURT OF APPEALS

ELEVENTH CIRCUIT

 DECEMBER 17, 2009

THOMAS K. KAHN

CLERK

[DO NOT PUBLISH]

IN THE UNITED STATES COURT OF APPEALS

FOR THE ELEVENTH CIRCUIT

________________________

No. 09-13240

Non-Argument Calendar

________________________

D.C. Docket No. 09-20068-CR-WJZ

UNITED STATES OF AMERICA,

Plaintiff-Appellee,

versus

HYMAN MCWILLIE,

Defendant-Appellant.

__________________________

Appeal from the United States District Court 

for the Southern District of Florida

_________________________

(December 17, 2009)

Before DUBINA, Chief Judge, WILSON and FAY, Circuit Judges.

PER CURIAM:

Robin J. Farnsworth, appointed counsel for Hyman McWillie in this direct

criminal appeal, has moved to withdraw from further representation of the

appellant and filed a brief pursuant to Anders v. California, 386 U.S. 738, 87 S.
Ct. 1396, 18 L. Ed. 2d 493 (1967). Our independent review of the entire record

reveals that counsel’s assessment of the relative merit of the appeal is correct. 

Because independent examination of the entire record reveals no arguable issues

of merit, counsel’s motion to withdraw is GRANTED, and McWillie’s conviction

and sentence are AFFIRMED.

2
IN THE COURT OF APPEALS OF THE STATE OF WASHINGTON

DIVISION ONE

STATE OF WASHINGTON, 

DEPARTMENT OF LABOR & 

INDUSTRIES,

Respondent,

v.

HOUSING AUTHORITY OF KING 

COUNTY,

Appellant.

 No. 80408-1-I

 ORDER GRANTING MOTION

 FOR RECONSIDERATION,

 WITHDRAWING OPINION,

 AND SUBSTITUTING OPINION

Respondent, Department of Labor and Industries, has filed a motion for 

reconsideration of the opinion filed in the above matter on June 8, 2020. The court has 

determined that respondent’s motion for reconsideration should be granted, the opinion

should be withdrawn and a substitute opinion be filed. Now, therefore, it is hereby

ORDERED that respondent’s motion for reconsideration is granted. It is further

ORDERED that the opinion filed on June 8, 2020, is withdrawn and a substitute 

opinion be filed.
### UNITEDSTATES ENVIRONMENTAL PROTECTIONAGENCY Region 1 5 Post Office Square, Suite 100 Boston, MA 02109-3312 

# APR 21 2012 Ms. Nancy Seidman Department of Environmental Protection One Winter Street 

### Boston, MA02108 Dear Ms. Seidman: By letter and attachments dated April 25, 2012, the Massachusetts Department ofEnvironmental Protection (DEP) submitted to the U.S. Environmental Protection Agency, Region I (EPA) a data substitution analysis for the Mount Greylock, Massachusetts ambient air ozone monitoring site, in accordance with the 

### regulatory requirements of40CFRPart 50 Appendix I . Section 2 .3 (b) ofAppendix I states:

" . . . .When computing whether minimum data completeness requirements have been met, meteorological or ambient data may be sufficient to demonstrate that meteorological conditions on missing days were not conducive to concentrations above the level of the standard . Missing days assumed less than the level of the standard are counted for purpose of meeting the minimumdata completeness requirement, subject tothe approval ofthe appropriate Regional Administrator ." The DEP analysis shows that meteorological and ambient data conditions for the missing days were not conducive to forming elevated concentrations of ground-level ozone which would have exceeded the 2008 8-hour ozone standard. Specifically, the analysis examines the temperature, cloud cover, and precipitation, as well as the ozone concentrations at surrounding monitors, for each missing day. Based on our reviewofthe DEP analysis, EPA concurs with DEP's determination that, for the dates listed in the Enclosure to this letter, the missing ozone data can be assumed less than the 2008 8-hour ozone standard. Therefore, EPA approves DEP°s request to allowmissing ambient air ozone concentrations for the days listed in the Enclosure to be counted when calculating the applicable data completeness requirements for the Mt . Greylock ozone monitor. Once DEP has flagged these data in EPA's Air Quality Data System(AQS), EPA will concur on these flags in AQS. Ifyou have any questions on this issue, please feel free to contact Robert Judge at (617) 918-8387, or 

### Richard Burkhart at (617) 918-16, Sincerely,

H . Curti-s Spalding Regional Administrator Enclosure cc: Eileen Hiney, MA DEP Tom McGrath, MA DEP

### Enclosure

Dates of missing data that can be assumed less than the 2008 8-hour ozone standard. Mt . Grevloclc?

. 2010 - 34 dals 

# Apr i,4, 6-30-- 27days May 3-4, 6-10-- 7 days Mt. Greylock, 2011- 39 days Apr 1-30-- 30days May 1-9 -- 9days
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2858 Introduced in House (IH)]

114th CONGRESS
  1st Session
                                H. R. 2858

 To phase out cosmetic animal testing and the sale of cosmetics tested 
                  on animals, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             June 23, 2015

   Ms. McSally (for herself, Mr. Beyer, Mr. Heck of Nevada, and Mr. 
  Cardenas) introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
 To phase out cosmetic animal testing and the sale of cosmetics tested 
                  on animals, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be referred to as the ``Humane Cosmetics Act''.

SEC. 2. DEFINITIONS.

    For purposes of this Act:
            (1) Cosmetic.--The term ``cosmetic'' has the meaning given 
        such term in section 201 of the Federal Food, Drug, and 
        Cosmetic Act (21 U.S.C. 321).
            (2) Cosmetic animal testing.--The term ``cosmetic animal 
        testing'' means the internal or external application or 
        exposure of any cosmetic to the skin, eyes, or other body part 
        of a live non-human vertebrate for purposes of evaluating the 
        safety or efficacy of a cosmetic.

SEC. 3. PROHIBITIONS.

    (a) Testing.--It shall be unlawful for any entity, whether private 
or governmental, to conduct or contract for cosmetic animal testing 
that--
            (1) occurs in the United States; and
            (2) is in or affecting interstate commerce.
    (b) Sale or Transport.--It shall be unlawful to sell, offer for 
sale, or transport in interstate commerce any cosmetic if the final 
product or any component thereof was developed or manufactured using 
cosmetic animal testing conducted or contracted for after the effective 
date specified in section 6(a).

SEC. 4. CIVIL PENALTIES.

    (a) In General.--In addition to any other penalties applicable 
under law, whoever violates any provision of this Act shall be assessed 
a civil penalty of not more than $10,000 for each such violation.
    (b) Multiple Violations.--Each violation of this Act with respect 
to a separate animal, and each day that a violation of this Act 
continues, constitutes a separate offense.

SEC. 5. EFFECTIVE DATES.

    (a) Prohibition on Cosmetic Animal Testing.--The prohibition 
specified in section 4(a) takes effect on the date that is 1 year after 
the date of enactment of this Act.
    (b) Prohibition on Sale.--The prohibition specified in section 4(b) 
takes effect on the date that is 3 years after the date of enactment of 
this Act.
                                 <all>
```